Skip to main content
Clinical Trials/DRKS00012888
DRKS00012888Not yet recruiting未知

Treatment strategies for Medication-related osteonecrosis of the jaw - a prospective, partially randomized patient preference trial - TEAM

Klinik und Poliklinik für Mund-, Kiefer- & Gesichtschirurgie, Universitätsklinikum Heidelberg, Ärztlicher Direktor: Prof. Dr. Dr. Jürgen Hoffmann0 sites90 target enrollmentStarted: May 17, 2018Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Patients with not infected medication-related osteonecrosis of the jaw (stadium I corresponding to AAOMS classification) who receiced or are receiving antiresorptive therapy (bisphosphonates or RANKL antibody) and who are planned for treatment at Clinic for craniofacial surgery of University hospital Heidelberg

Exclusion Criteria

  • 1. Previous history of a radiation to the head neck region 2. Known metastasis of the jaw

Investigators

Sponsor
Klinik und Poliklinik für Mund-, Kiefer- & Gesichtschirurgie, Universitätsklinikum Heidelberg, Ärztlicher Direktor: Prof. Dr. Dr. Jürgen Hoffmann

Similar Trials